• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双荧光剪接报告基因小基因鉴定出一种反义寡核苷酸以跳跃该基因的外显子v8

Dual Fluorescence Splicing Reporter Minigene Identifies an Antisense Oligonucleotide to Skip Exon v8 of the Gene.

作者信息

Fukushima Sachiyo, Farea Manal, Maeta Kazuhiro, Rani Abdul Qawee Mahyoob, Fujioka Kazumichi, Nishio Hisahide, Matsuo Masafumi

机构信息

Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.

Research Center for Locomotion Biology, Kobe Gakuin University, Kobe 651-2180, Japan.

出版信息

Int J Mol Sci. 2020 Nov 30;21(23):9136. doi: 10.3390/ijms21239136.

DOI:10.3390/ijms21239136
PMID:33266296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7729581/
Abstract

Splicing reporter minigenes are used in cell-based in vitro splicing studies. Exon skippable antisense oligonucleotide (ASO) has been identified using minigene splicing assays, but these assays include a time- and cost-consuming step of reverse transcription PCR amplification. To make in vitro splicing assay easier, a ready-made minigene (FMv2) amenable to quantitative splicing analysis by fluorescence microscopy was constructed. FMv2 was designed to encode two fluorescence proteins namely, mCherry, a transfection marker and split eGFP, a marker of splicing reaction. The split eGFP was intervened by an artificial intron containing a multicloning site sequence. Expectedly, FMv2 transfected HeLa cells produced not only red mCherry but also green eGFP signals. Transfection of FMv2v8, a modified clone of FMv2 carrying an insertion of exon v8 in the multicloning site, that was applied to screen exon v8 skippable ASO, produced only red signals. Among seven different ASOs tested against exon v8, ASO#14 produced the highest index of green signal positive cells. Hence, ASO#14 was the most efficient exon v8 skippable ASO. Notably, the well containing ASO#14 was clearly identified among the 96 wells containing randomly added ASOs, enabling high throughput screening. A ready-made FMv2 is expected to contribute to identify exon skippable ASOs.

摘要

剪接报告基因微型基因用于基于细胞的体外剪接研究。通过微型基因剪接试验已鉴定出外显子可跳跃反义寡核苷酸(ASO),但这些试验包括逆转录PCR扩增这一耗时且昂贵的步骤。为了使体外剪接试验更简便,构建了一种适用于通过荧光显微镜进行定量剪接分析的即用型微型基因(FMv2)。FMv2被设计用于编码两种荧光蛋白,即作为转染标记的mCherry和作为剪接反应标记的分裂型eGFP。分裂型eGFP被一个包含多克隆位点序列的人工内含子所间隔。不出所料,转染FMv2的HeLa细胞不仅产生了红色的mCherry信号,还产生了绿色的eGFP信号。转染FMv2v8(FMv2的一个修饰克隆,在多克隆位点插入了外显子v8)用于筛选可跳跃外显子v8的ASO,结果只产生了红色信号。在针对外显子v8测试的七种不同ASO中,ASO#14产生的绿色信号阳性细胞指数最高。因此,ASO#14是最有效的可跳跃外显子v8的ASO。值得注意的是,在随机添加ASO的96孔板中能够清晰地识别出含有ASO#14的孔,从而实现高通量筛选。预计这种即用型FMv2将有助于鉴定可跳跃外显子的ASO。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/7a50a4db64cb/ijms-21-09136-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/77a7753f57c5/ijms-21-09136-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/bd2baef7caa7/ijms-21-09136-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/7093507653d0/ijms-21-09136-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/6c7fc71eeff2/ijms-21-09136-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/7a50a4db64cb/ijms-21-09136-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/77a7753f57c5/ijms-21-09136-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/bd2baef7caa7/ijms-21-09136-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/7093507653d0/ijms-21-09136-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/6c7fc71eeff2/ijms-21-09136-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c227/7729581/7a50a4db64cb/ijms-21-09136-g005.jpg

相似文献

1
Dual Fluorescence Splicing Reporter Minigene Identifies an Antisense Oligonucleotide to Skip Exon v8 of the Gene.双荧光剪接报告基因小基因鉴定出一种反义寡核苷酸以跳跃该基因的外显子v8
Int J Mol Sci. 2020 Nov 30;21(23):9136. doi: 10.3390/ijms21239136.
2
Repair of aberrant splicing in growth hormone receptor by antisense oligonucleotides targeting the splice sites of a pseudoexon.通过针对假外显子剪接位点的反义寡核苷酸修复生长激素受体的异常剪接。
J Clin Endocrinol Metab. 2010 Jul;95(7):3542-6. doi: 10.1210/jc.2009-1968. Epub 2010 Apr 28.
3
Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.通过使用灵敏且特异的双色荧光微型基因检测法鉴定调控FGFR2剪接的RNA结合蛋白。
RNA. 2006 Jun;12(6):1129-41. doi: 10.1261/rna.34906. Epub 2006 Apr 7.
4
The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.CD44可变v9外显子包含一个对SR蛋白9G8、ASF/SF2和SRp20有反应的剪接增强子。
J Biol Chem. 2003 Aug 29;278(35):32943-53. doi: 10.1074/jbc.M301090200. Epub 2003 Jun 24.
5
Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.细胞毒性药物治疗后WT1基因表达和外显子5剪接的破坏:外显子5的反义下调改变靶基因表达并抑制细胞存活。
Mol Cancer Ther. 2004 Nov;3(11):1467-84.
6
Surface PD-1 expression in T cells is suppressed by HNRNPK through an exonic splicing silencer on exon 3.T 细胞表面 PD-1 的表达受 HNRNPK 通过外显子 3 上的外显子剪接沉默子抑制。
Inflamm Res. 2024 Jul;73(7):1123-1135. doi: 10.1007/s00011-024-01887-4. Epub 2024 May 2.
7
Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping.通过反义寡核苷酸介导的外显子跳跃实现精准医疗。
Trends Pharmacol Sci. 2018 Nov;39(11):982-994. doi: 10.1016/j.tips.2018.09.001. Epub 2018 Sep 30.
8
Fluorescent Protein-Based Quantification of Alternative Splicing of a Target Cassette Exon in Mammalian Cells.基于荧光蛋白的哺乳动物细胞中目标盒式外显子可变剪接的定量分析
Methods Enzymol. 2016;572:255-68. doi: 10.1016/bs.mie.2016.02.007. Epub 2016 Mar 11.
9
Intronic UGG repeats coordinate splicing of CD44 alternative exons v8 and v9.内含子UGG重复序列协调CD44可变外显子v8和v9的剪接。
Biochem Biophys Res Commun. 2005 Oct 21;336(2):667-73. doi: 10.1016/j.bbrc.2005.08.153.
10
In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs.通过反义寡核苷酸和修饰的小核 RNA 体外纠正 LGMD2A 中的假外显子生成深内含子突变。
Hum Mutat. 2013 Oct;34(10):1387-95. doi: 10.1002/humu.22379. Epub 2013 Aug 7.

引用本文的文献

1
Expansion of Splice-Switching Therapy with Antisense Oligonucleotides.反义寡核苷酸介导的剪接转换疗法的扩展
Int J Mol Sci. 2025 Mar 4;26(5):2270. doi: 10.3390/ijms26052270.
2
Tailored antisense oligonucleotides designed to correct aberrant splicing reveal actionable groups of mutations for rare genetic disorders.针对异常剪接设计的定制反义寡核苷酸揭示了罕见遗传疾病中可操作的突变群。
Exp Mol Med. 2024 Aug;56(8):1816-1825. doi: 10.1038/s12276-024-01292-1. Epub 2024 Aug 1.
3
Successful skipping of abnormal pseudoexon by antisense oligonucleotides in vitro for a patient with beta-propeller protein-associated neurodegeneration.

本文引用的文献

1
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5.开发一种针对 X 连锁 Alport 综合征的外显子跳跃治疗方法,该方法针对 COL4A5 中的截断变异。
Nat Commun. 2020 Jun 2;11(1):2777. doi: 10.1038/s41467-020-16605-x.
2
Development of an Antisense Oligonucleotide-Mediated Exon Skipping Therapeutic Strategy for Mucolipidosis II: Validation at RNA Level.开发一种反义寡核苷酸介导的外显子跳跃治疗策略用于黏脂贮积症 II:在 RNA 水平的验证。
Hum Gene Ther. 2020 Jul;31(13-14):775-783. doi: 10.1089/hum.2020.034. Epub 2020 May 20.
3
The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy.
体外反义寡核苷酸成功跳过β-三叶螺旋蛋白相关神经退行性变患者的异常假外显子。
Sci Rep. 2024 Mar 18;14(1):6506. doi: 10.1038/s41598-024-56704-z.
4
Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular Dystrophy.反义寡核苷酸介导的外显子跳跃疗法:从杜氏肌营养不良症蔓延开来的精准医学
JMA J. 2021 Jul 15;4(3):232-240. doi: 10.31662/jmaj.2021-0019. Epub 2021 Jul 9.
第十种获批的寡核苷酸疗法:用于杜氏肌营养不良症的golodirsen。
Nucleic Acid Ther. 2020 Apr;30(2):67-70. doi: 10.1089/nat.2020.0845. Epub 2020 Feb 11.
4
Contribution of Rare Variants of the Gene to the Missing Heritability of Serum Urate Levels.基因罕见变异对血清尿酸水平遗传度缺失的贡献。
Genetics. 2020 Apr;214(4):1079-1090. doi: 10.1534/genetics.119.303006. Epub 2020 Jan 31.
5
Exon skipping induced by nonsense/frameshift mutations in DMD gene results in Becker muscular dystrophy.无义/移码突变导致 DMD 基因外显子跳跃,从而导致 Becker 型肌营养不良症。
Hum Genet. 2020 Feb;139(2):247-255. doi: 10.1007/s00439-019-02107-4. Epub 2020 Jan 9.
6
Antisense-Mediated Skipping of Dysferlin Exons in Control and Dysferlinopathy Patient-Derived Cells.反义介导的肌营养不良蛋白外显子跳跃在对照和肌营养不良蛋白病患者来源细胞中的研究。
Nucleic Acid Ther. 2020 Apr;30(2):71-79. doi: 10.1089/nat.2019.0788. Epub 2019 Dec 23.
7
ExonSkipDB: functional annotation of exon skipping event in human.外显子跳跃数据库:人类外显子跳跃事件的功能注释。
Nucleic Acids Res. 2020 Jan 8;48(D1):D896-D907. doi: 10.1093/nar/gkz917.
8
Minigene splicing assessment of 20 novel synonymous and intronic glucokinase gene variants identified in patients with maturity-onset diabetes of the young.对在青少年发病的成年型糖尿病患者中发现的 20 种新型同义突变和内含子葡萄糖激酶基因变异进行迷你基因剪接评估。
Hum Mutat. 2020 Jan;41(1):129-132. doi: 10.1002/humu.23919. Epub 2019 Nov 15.
9
Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides.通过剪接调节反义寡核苷酸降低整合素 α4 活性。
Sci Rep. 2019 Sep 10;9(1):12994. doi: 10.1038/s41598-019-49385-6.
10
Determination of the pathogenicity of known COL4A5 intronic variants by in vitro splicing assay.通过体外剪接试验确定已知 COL4A5 内含子变异的致病性。
Sci Rep. 2019 Sep 3;9(1):12696. doi: 10.1038/s41598-019-48990-9.